Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TRK-950
i
Other names:
TRK-950, TRK950, TRK 950
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Toray
Drug class:
Caprin-1 inhibitor
‹
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
CAPRIN-1 expression
Gastroesophageal Junction Adenocarcinoma
CAPRIN-1 expression
Gastroesophageal Junction Adenocarcinoma
ramucirumab + TRK-950
Sensitive: C3 – Early Trials
ramucirumab + TRK-950
Sensitive
:
C3
ramucirumab + TRK-950
Sensitive: C3 – Early Trials
ramucirumab + TRK-950
Sensitive
:
C3
CAPRIN-1 expression
Gastric Cancer
CAPRIN-1 expression
Gastric Cancer
ramucirumab + TRK-950
Sensitive: C3 – Early Trials
ramucirumab + TRK-950
Sensitive
:
C3
ramucirumab + TRK-950
Sensitive: C3 – Early Trials
ramucirumab + TRK-950
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login